Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain

Go back to Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
(NASDAQ: LFWD) Delayed: 7.00 --0 (-0%)
Previous Close $7.00    52 Week High
Open $7.00    52 Week Low
Day High $7.00    P/E N/A 
Day Low $7.00    EPS
Volume 31